GALLENGA, Carla Enrica
 Distribuzione geografica
Continente #
NA - Nord America 2.573
AS - Asia 2.049
EU - Europa 1.245
SA - Sud America 358
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 64
OC - Oceania 17
Totale 6.435
Nazione #
US - Stati Uniti d'America 2.457
SG - Singapore 704
IT - Italia 404
PL - Polonia 343
CN - Cina 325
BR - Brasile 263
VN - Vietnam 255
HK - Hong Kong 193
BD - Bangladesh 145
DE - Germania 108
IN - India 91
GB - Regno Unito 90
JP - Giappone 60
CA - Canada 59
ID - Indonesia 57
FR - Francia 54
AR - Argentina 41
FI - Finlandia 41
TR - Turchia 39
RU - Federazione Russa 36
MX - Messico 34
TH - Thailandia 32
NL - Olanda 31
UA - Ucraina 30
ES - Italia 25
SE - Svezia 24
IQ - Iraq 19
MY - Malesia 16
CO - Colombia 15
PK - Pakistan 14
VE - Venezuela 14
ZA - Sudafrica 14
AU - Australia 13
EG - Egitto 12
SA - Arabia Saudita 12
KR - Corea 11
PH - Filippine 11
IL - Israele 10
BE - Belgio 9
EC - Ecuador 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
TN - Tunisia 8
UZ - Uzbekistan 8
CL - Cile 7
GR - Grecia 7
KE - Kenya 6
KZ - Kazakistan 6
NP - Nepal 6
AL - Albania 5
LT - Lituania 5
RO - Romania 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
IE - Irlanda 4
JM - Giamaica 4
JO - Giordania 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AZ - Azerbaigian 3
CR - Costa Rica 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
TW - Taiwan 3
UY - Uruguay 3
BM - Bermuda 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
Totale 6.303
Città #
Singapore 422
Ashburn 354
Warsaw 338
San Jose 308
Hong Kong 178
Fairfield 127
Santa Clara 127
Beijing 112
Chandler 97
Council Bluffs 86
Ho Chi Minh City 81
Woodbridge 80
Ann Arbor 75
Houston 67
Los Angeles 62
New York 59
Hanoi 56
Seattle 55
Munich 54
Milan 50
Tokyo 46
Wilmington 46
Cambridge 42
São Paulo 38
Dallas 37
Jakarta 37
Ferrara 35
Jacksonville 28
Lauterbourg 27
Chicago 25
Pescara 25
Toronto 25
Denver 24
Orem 24
Phoenix 20
Princeton 20
Helsinki 19
Rome 19
Shanghai 19
Mexico City 18
Izmir 17
Da Nang 16
Verona 16
Boardman 15
Chennai 15
Brooklyn 14
Montreal 14
Buffalo 13
Raipur 13
Redwood City 13
Atlanta 12
Turku 12
Haiphong 11
Stockholm 11
Bangkok 10
Bologna 10
Boston 10
Frankfurt am Main 10
London 10
The Dalles 10
Brussels 9
Hefei 9
Johannesburg 9
Naples 9
Norwich 9
Osaka 9
Poplar 9
San Diego 9
Amsterdam 8
Curitiba 8
Dong Ket 8
Mumbai 8
Nanjing 8
New Delhi 8
Paris 8
Adelaide 7
Biên Hòa 7
Cagliari 7
Chon Buri 7
Manchester 7
Nuremberg 7
Querétaro 7
Rio de Janeiro 7
San Francisco 7
Tashkent 7
Brasília 6
Buenos Aires 6
Columbus 6
Jeddah 6
Moscow 6
Petaling Jaya 6
Phuket 6
Salt Lake City 6
Turin 6
Ankara 5
Baghdad 5
Bremen 5
Bắc Ninh 5
Cairo 5
City of London 5
Totale 3.896
Nome #
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study 436
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 371
Determination of the soluble form of the P2X7 receptor in aqueous humour, vitreous humour and serum under normal and pathological conditions: sP2X7R as an indicator of ocular inflammatory status 368
Psoriatic uveitis is not an exploded myth 276
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 272
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: A better understanding of the pathophysiology using the newest genetic strategies 269
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection 236
The role of gene therapy in the treatment of retinal diseases: A review 223
A New Pharmacological Approach Based on Remdesivir Aerosolized Administration on SARS-CoV-2 Pulmonary Inflammation: A Possible and Rational Therapeutic Application 221
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma 202
Diagnosis of a Neonatal Ophthalmic Discharge, Ophthalmia Neonatorum, in the “Molecular Age”: Investigation for a Correct Therapy 195
Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation 157
Inflammaging: should this term be suitable for age related macular degeneration too? 147
How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy 147
About Chlamydia trachomatis. Reply to Garcia-Teillard et al. Trachoma and the Importance of Sexual Infective Route in Developed Countries. Comment on “Gallenga et al. Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View. Pathogens 2023, 12, 1419” 143
Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines 137
Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects 134
Mast cell cytokines il-1, il-33, and il-36 mediate skin inflammation in psoriasis: A novel therapeutic approach with the anti-inflammatory cytokines il-37, il-38, and il-1ra 127
Retinitis pigmentosa and cystoid macular pattern 123
Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37 123
Mast cells mediate rheumatoid arthritis—inhibitory role of IL-37 114
Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37 108
Who is Afraid of a Bug Mantled Like Zorro? 104
New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37 97
Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic 96
Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View 91
Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37 87
Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis 85
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 79
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 78
Floppy Iris Risk Factors 73
New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help? 60
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy 59
Anaphylaxis is a rare reaction in COVID-19 vaccination 54
Molecular Mechanisms Related to Oxidative Stress in Retinitis Pigmentosa 54
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 52
Inquadramento diagnostico dell’Orbitopatia di Graves 48
CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37 46
Contribution of mast cells in SARS-CoV-2-induced inflammation 46
Novel evidence of ghrelin and growth hormone segretagogue receptor expression by human ocular tissues 43
Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37 42
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra) 38
RETINAL PHAKOMATOSIS AND VON HIPPEL–LINDAU PERIPHERAL CAPILLARY HEMANGIOBLASTOMA: PROPOSAL FOR STAGED SURGERY 37
Visual Performance and Quality of Life after Femtosecond Laser-Assisted Cataract Surgery with Trifocal IOLs Implantation 31
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies 29
Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects 28
Suggestions on gut-eye cross-talk: about the chalazion 28
Mast cells and virus 27
Interleukin-1 family cytokines and mast cells: activation and inhibition 26
Short term effects of extremely low irradiance photobiomodulation on retinal function, in age related macular degeneration 25
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37 23
Mesenchymal stem cells and IL-37: a powerful combination 23
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19 23
Powerful anti-inflammatory action of luteolin: Potential increase with IL-38 23
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19 22
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators 22
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem 22
Mast cell virus infection and inflammatory cytokines 22
Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity 22
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 22
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy 19
Virtual learning solutions in COVID-19 era: University Italian Ophthalmology department perspective 19
Impact of mast cells in fibromyalgia and low‐grade chronic inflammation: Can IL‐37 play a role? 19
SARS-CoV-2, which induces COVID-19, causes Kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines 17
Monoclonal antibody therapy in COVID-19 17
Impact of mold on mast cell-cytokine immune response 16
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? 12
Totale 6.435
Categoria #
all - tutte 28.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022188 18 24 10 11 8 17 5 13 10 13 13 46
2022/2023244 19 15 13 18 33 25 39 21 29 10 11 11
2023/2024200 14 19 6 9 13 25 8 12 1 15 16 62
2024/2025949 24 20 84 31 95 113 25 45 148 93 120 151
2025/20263.644 278 111 294 525 444 256 337 220 339 433 258 149
2026/2027142 142 0 0 0 0 0 0 0 0 0 0 0
Totale 6.435